This is the authors' abstract. We don't add key points for this paper.
This invited commentary refers to ‘Evaluation of the effect of proximal massage and palm fisting in reducing the risk of peripheral venous catheter-related phlebitis: randomized control study’, by B. Tosun et al., https://doi.org/10.1093/eurjcn/zvae024. Adverse events (AEs) and risks associated with healthcare remain a major challenge for patients’ safety in the hospital. In fact, AEs are confirmed as a public health problem globally.1 However, the threat to patient safety is avoidable in nearly half of patients and may cause death, disability, and suffering for the patients.1–3 Moreover, the economic costs of safety lapses are high.1 Adverse events caused by medication are reported as the most frequent, followed by AEs related to surgery, falls, pressure ulcers, and healthcare-associated infections (HAIs).2,3 However, phlebitis from peripheral intravenous catheters (PIVCs), which is defined as an inflammation of the tunica intima of the actual vein, is rarely mentioned in this context. The reason for underreporting may be that most cases of phlebitis from PIVCs heal quickly, are considered unrelated to HAI, and therefore are not categorized as an AE even though PIVCs may be the underlying aetiology of life-threatening bloodstream infections.4,5 Despite the absence of infections or death, healthcare providers must recognize that phlebitis causes suffering for the patients, which from a patient perspective delays their recovery.6 In relation to HAI, patients’ experience could be expressed as a continuum of physical and emotional distress because of their situation, regardless of physical symptoms.7 A quality improvement project from our group showed that 44% of the patients developed amiodarone-induced phlebitis, and 70–90% of the patients were inflicted with harm, such as pain, swelling, and redness.8 Furthermore, patients with chemotherapy-induced phlebitis reported arm aches and visible puckering from the wrist to past the elbow at 6-month follow-up.9 Despite this, there is a missing spotlight on this issue, as well as lack of consensus on how to prevent PIVC-related phlebitis. Tosun et al.10 suggest that phlebitis can be prevented by using proximal massage and palm fisting. The rationale for these interventions were based on previous studies reporting preventive effect of enhancing blood circulation in the hand muscles. The study randomized 72 patients, allocated to receive proximal massage and palm fisting in addition to standard nursing care (intervention group) or standard nursing care alone (control group). The control group experienced a notably higher occurrence of PIVC-related phlebitis in comparison to the intervention group both after 48 and 96 h. Another study showed that the use of hot applications, which were supposed to have a relaxing effect on muscle and connective tissue, as well as dilation of vessels, was more effective than palm fisting. Therefore, these authors recommend hot application with temperature range between 40 and 45○C to prevent phlebitis.11 Several other methods, such as external application of aloe vera, 75% alcohol, or 50–75% magnesium sulfate, have been evaluated to prevent PIVC-related phlebitis, without strong evidence for the prevention of phlebitis with such external applications.12 Nevertheless, reducing the risk of PIVC-related phlebitis requires a complex intervention including several sources of risk.4 Such complex interventions require primarily good nursing skills within a resilient healthcare system. Based on this, the interventions in this study could, from a clinical view, provide some challenges. For example, most critically ill, in-hospital patients will not be able to cooperate with the nurses to complete proximal massage and palm fisting in an appropriate way. Therefore, identifying the fidelity, such as the degree to which the proximal massage and palm fisting are implemented as intended among all types of patients in a clinical hospital setting, is recommended. Our study reported limitations according to implementing in-hospital guidelines to prevent amiodarone-induced phlebitis.8 This is not an unknown phenomenon as several factors that make implementation difficult are already described. For instance, knowledge, attitudes, and beliefs are well known barriers to the implementation of evidence-based practice among nurses.13 Therefore, interventions with a solid rationale, evaluated in studies with strong methodological quality, as well as interventions that are feasible in clinical practise, are necessary to strengthen the nurses’ confidence and trust to adhere to the recommendations. Furthermore, a deeper understanding of the criteria of phlebitis has an underrated value to provide safety in healthcare. However, although there are dozens of assessment instruments for phlebitis, their measure properties are rare.14 This contributes to a wide variety in reporting phlebitis and thereafter affects the time nurses consider to remove the PIVC in clinical practise. A newer assessment tool, the Peripheral Intravenous Catheter mini Questionnaire (PIVC-miniQ), has been shown to effectively detect the development of phlebitis signs. The PIVC-miniQ was found to be feasible, reliable, and efficient for quality control in clinical practice.15 So, to improve the patient safety, PIVC-miniQ could be used to early detect the onset of a phlebitis to avoid serious consequences for the patients. However, the finding in this study certainly contributes with a new piece of knowledge in the search to find interventions to prevent the risk of phlebitis and eliminate a threat to patient safety in hospital care. This is a highly appreciated finding, but limits to a few patient groups that are able to follow up. Our united knowledge must furthermore be included in clinical practice guidelines that healthcare providers must commit to follow. This invited commentary is an urgent reminder to policy-makers, healthcare organizations, and healthcare providers of the need for continuing improvement of patient safety in hospital care. Firstly, there is a need to include PIVC-related phlebitis in the registration of AE, to increase the knowledge of this phenomenon. Secondly, it is time to acknowledge that prevention of PIVC-related phlebitis require valid and reliable in-hospital guidelines. Thirdly, exploring the patients’ experience can help understand important key quality of care components.16 Finally, by creating an interaction between these approaches, healthcare providers could gain enough knowledge to develop a roadmap aiming to reduce the risk of PIVC-related phlebitis in hospital care. No new data were generated or analysed in support of this research.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Brørs et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: